Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

The risk of developing pancreatitis is elevated in type 2 diabetes and obesity. Cases of pancreatitis have been reported in type 2 diabetes patients treated with GLP-1 (GLP-1R) receptor agonists. To examine whether the GLP-1R agonist exenatide potentially induces or modulates pancreatitis, the effec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatarkiewicz, Krystyna, Smith, Pamela A., Sablan, Emmanuel J., Polizzi, Clara J., Aumann, Donald E., Villescaz, Christiane, Hargrove, Diane M., Gedulin, Bronislava R., Lu, Melissa G. W., Adams, Lisa, Whisenant, Tina, Roy, Denis, Parkes, David G.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Physiological Society 2010
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3006257/
https://ncbi.nlm.nih.gov/pubmed/20923958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00479.2010
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares